巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    KalVista Pharmaceuticals

    KALV
    8.580
    0.080
    0.94%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・KalVista Pharmaceuticals - 延遲價格・最後更新於 26/05 12:14
    最高位
    8.860
    最低位
    8.510
    開市價
    --
    前收市價
    8.500
    成交量(千)
    13.82
    成交額(百萬)
    1.13
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    210.58
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    30.700 - 8.480
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    KalVista Pharmaceuticals
    證券代碼
    KALV.US
    所屬板塊
    Biotechnology
    公司業務
    KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates through the region of the United States.
    發行量
    24436492
    公司總部
    55 Cambridge Parkway, Suite 901 East
    公司網址
    https://www.kalvista.com
    公司電郵
    ir@kalvista.com
    公司電話
    +1 857 999-0075
    暫無內容

    關於

    KalVista Pharmaceuticals(KALV.US)所屬的行業板塊為Biotechnology。
    KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates through the region of the United States.
    詳細公司背景可參考: https://www.kalvista.com